Endocrine IPS, PLLC — Houston, Texas

Endocrine IPS, PLLC is a clinical research site located in Houston, Texas, United States 77079.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Endocrine IPS, PLLC has participated in 5 clinical trials.

Therapeutic areas: Diabetic Peripheral Neuropathic Pain, Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus With Diabetic Nephropathy.

Sponsors: Reata, a wholly owned subsidiary of Biogen, Anji Pharma, Akebia Therapeutics.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Endocrine IPS, PLLC?

Endocrine IPS, PLLC has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Endocrine IPS, PLLC conducted?

Endocrine IPS, PLLC has 5 clinical trials on record. Their work covers Diabetic Peripheral Neuropathic Pain, Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus With Diabetic Nephropathy.

Is Endocrine IPS, PLLC accredited by Crixeo Health?

Endocrine IPS, PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Endocrine IPS, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.